AI in drug development is a vague term that might mean many things, and today, Owkin is announcing it has enrolled the first patient in a phase 1 study of OKN4395, its “AI-optimized” candidate for ...
THE KASH CACHE: Of Patel and Gabbard, it’s the FBI nominee who appears on far stronger footing. One tangible example of that is that Sen. Thom Tillis (R-N.C.), whose support for Defense Secretary Pete ...